Roughly one in ten Americans suffers from major depressive disorder (MDD) at any given time. In total, up to 20 percent of ...

Peter Moulding joined a clinical trial for the drug AMP945 not really knowing whether it would help him with deadly stage ...

Many people still believe that building muscle means living at the gym and constantly training. Fresh evidence shows it's ...

A compound best known for giving almonds and apricots their aroma may be the key to defeating hard-to-kill cancer cells. Japanese researchers found that benzaldehyde can stop the shape-shifting ...

Researchers identified a unique protein signature in the blood of BMD and LGMD patients that may reflect disease progression.

Aberrations in fibroblast growth factor receptors FGFR2/3 are major drivers of many cancers—including intrahepatic cholangiocarcinoma, endometrial ...

Cancer cells have the capacity to multiply rapidly. The aggressive cancer cells undergo conversion from their tightly ...

Ensem Therapeutics doses first patient in phase 1/2 study of ETX-636, a novel allosteric pan-mutant-selective PI3Ka inhibitor and degrader: Waltham, Massachusetts Thursday, July 3 ...

People with autoimmune skin diseases had significantly better cancer survival outcomes than others. Survival benefits were ...

The cellular action that enables the mouth's interior lining to heal quicky and without scarring has always been a mystery, ...

During therapy, some cancer cells evolve to escape elimination. Newer anticancer drugs that can overcome this resistance are necessary. Now, researchers from Japan demonstrate that aromatic ...